CU Anschutz Cancer Center gynecologic oncologist Christine Walsh, MD, MS, explains the fourth most common cancer among U.S. women.

For women with cancer, there are many therapies to help control their disease. But sometimes, those treatments can cause premature menopause.

The metabolite αKG promotes carnitine synthesis and increases site-specific histone acetylation, thereby promoting homologous recombination-mediated DNA repair, which has potential implications f...

Matt Sikora, PhD, seeks better answers for lobular breast cancer, which can be harder to detect & has lower survival rates after several years than other types.

Matt Sikora, PhD, seeks better answers for lobular breast cancer, which can be harder to detect & has lower survival rates after several years than other types.

The firm presented data at AACR that showed the test had high accuracy when distinguishing ovarian cancer at early stages.

The benefits of women’s health research haven’t been limited to women. But actions by the Trump administration threaten to dismantle the hard-won progress in this area.

Four leading ovarian cancer research charities from four countries are funding a new AI Accelerator Grant in partnership with Microsoft’s AI for Good Lab to supercharge the next cancer research breakt...

Symptoms occur in up to 75% of patients with early-stage ovarian cancer; as such, using a symptom inventory (SI) to stratify which patients should rec…

Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the cutting edge to detect and prevent ovarian cancer.

Approximately 50% of cancers exhibit decreased CDKN2A expression ( CDKN2A Low), which is linked to immune checkpoint blockade (ICB) resistance. While CDKN2A is traditionally recognized as a tumor supp...